Sagewood Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Sell
6,484
-9
-0.1% -$1.72K 0.32% 54
2026
Q1
$1.19M Buy
6,493
+594
+10% +$109K 0.37% 50
2025
Q4
$1.04M Buy
+5,899
New +$964K 0.37% 48

Other funds holding BIIB

Sagewood Asset Management's BIIB Position: Q2 2026 in Review

Sagewood Asset Management reduced its Biogen (BIIB) stake by 0.14% in Q2 2026, selling an estimated $1.72K and leaving 6,484 shares worth $1.4M. The position accounts for 0.32% of the portfolio, ranked #54.

Sagewood Asset Management first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Sagewood Asset Management held 6,484 shares of Biogen worth $1.4M as of Q2 2026.
  • Sagewood Asset Management sold 9 Biogen shares in Q2 2026, an estimated $1.72K.
  • Biogen made up 0.32% of Sagewood Asset Management's portfolio in Q2 2026, its #54 holding.
  • Sagewood Asset Management first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Sagewood Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.